乳腺癌术前外周血循环肿瘤细胞计数的临床应用价值研究-东南大学学报医学版

乳腺癌术前外周血循环肿瘤细胞计数的临床应用价值研究

单位：东南大学附属江阴市人民医院乳甲外科, 江苏江阴 214400

分类号：R737.9

出版年·卷·期（页码）：2018·37·第二期（272-276）

摘要：

目的：探讨乳腺癌患者术前循环肿瘤细胞（CTCs）检测与术后临床病理特征的关系，研究其临床应用价值。方法：采用免疫磁珠阴性富集联合免疫荧光染色法检测60例乳腺良性结节患者及136例乳腺癌患者术前外周血CTCs水平，分析CTCs与患者临床病理特征的关系。结果：136例乳腺癌患者CTCs总阳性率为46.32%，在乳腺良性结节患者中未检出（P<0.01）。乳腺癌CTCs阳性率在年龄、肿瘤大小、Grade分级、淋巴结转移、AJCC分期、ER、PR、Ki67状态、分子分型表达差异均无统计学意义（P>0.05）。Her2阳性组低于Her2阴性组（36.2%vs 51.7%），但差异无统计学意义。多因素分析表明CTCs阳性水平与AJCC分期及Her2状态具有相关性（P=0.011及P=0.057）。结论：乳腺癌术前CTCs表达阳性率与术后病理AJCC分期及Her2状态相关，术前检测对病情评估有一定的临床应用价值。

Objective:To explore the relationship between the presence of circulating tumor cells(CTCs)before operation and the clinicopathologic characteristics after operation in breast cancer patients and study the clinical value. Methods:136 cases of patients with breast cancer and 60 cases of patients with benign nodule were chosen before operation, then those CTCs were collected based on negative immunomagnetic separation and then dectected by imFISH method in order to analyze the relationship between the positive rate of CTCs and clinicopathologic characteristics. Results:CTCs were detected in 46.32% of breast cancer, and in 0 of benign nodule(P<0.01). The CTCs positive rates in breast cancer patients showed no significant difference among age,tumor size, histological grade,lymph node metastasis, AJCC stage, ER status,PR status,Ki67 status or molecular types(P>0.05). Her2 positive breast cancer detected less CTCs than Her2 negative breast cancer, although this difference as measured was not significant(P>0.05). Multivariate analysis showed CTCs enumeration and AJCC stage, Her2 status were relevant(P=0.011 and P=0.057). Conclusion:AJCC stage and Her2 status are the primary tumor characteristic that correlates with the presence of CTCs in breast cancer patients before operation, and CTCs detection before operation in breast cancer patients has great clinical value.

参考文献：

[1] ASHWORTH T.A case of cancer in which cells similar to those in the tumors were seen in the blood after death[J]. Aust Med J,1869,14(5):146-149.
[2] NAKAMURA S,YAGATA H,OHNO S,et al.Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer[J].Breast Cancer,2010,17(3):199-204.
[3] HOU J M,KREBS M G,SLOANE R,et al.Molecular features and clinical relevance of circulating tumor cells(CTC)and circulating tumor microemboli (CTM)in patients with small cell lung cancer(SCLC)[J].Clinical & Experimental Metastasis,2011,28(2):221-222.
[4] EISENHAUER E A,THERASSE P,BOGAERTS J,et al.New response evaluation criteria in solid tumours:revised RECIST guideline(version1.1)[J].Eu J Cancer,2009,45(2):228-247.
[5] 姜华,国光菊,刘刚.超声引导下组织切除活检对乳腺癌Ⅱ、Ⅲ级预防的价值[J].现代医学,2011,39(5):575-577.
[6] HOU J M,KREBS M G,LANCASHIRE L,et al.Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer[J].J Clin Oncol,2012,30(5):525-532.
[7] KREBS M G,SLOANE R,PRIEST L,et al.Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer[J].J Clin Oncol,2011,29(12):1556-1563.
[8] ALIX-PANABIERES C,RIETHDORF S,PANTEL K.Circulating tumor cells and bone marrow micrometastasis[J].Clin Cancer Res,2008,14(16):5013-5021.
[9] 蔡清清,黄慧强,林天歆,等.乳腺癌患者外周血中循环癌细胞的检测及其临床意义[J].癌症,2005,24(7):837-841.
[10] KRISHNAMURTHY S,CRISTOFANILLI M,SINGH B,et al.Detection of minimal residual disease in blood and bone marrow in early stage breast cancer[J].Cancer,2010,116(14):3330-3337.
[11] LANG J L,MOSALPURIA K,CRISTOFANILLI M,et al.HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer[J].Breast Cancer Res Treat,2009,113(3):501-507.
[12] FERRO P,FRANCESCHINI M C,BACIGALUPO B,et al.Detection of circulating tumor cells in breast cancer patients using human mammaglobin RT-PCR:association with clinical prognostic factors[J].Anticancer Res,2010,30(6):2377-2382.
[13] 原晓燕.可手术乳腺癌患者的循环肿瘤细胞与临床病理特征的关系[J].解放军医学院学报,2016,37(5):429-431.
[14] 李蕾,江泽飞.循环肿瘤细胞检测在不同阶段不同类型乳腺癌中的应用[J].中国癌症杂志,2013,23:570-575.
[15] WU C,HAO H J,LI L Y,et al.Preliminary investigation of the clinical significance of detecting circulating tumor cells enriched from lung cancer patients[J].J Thorac Oncol,2009,4(1):30-36.
[16] COELLO M C,LUKETICH J D,LITLE V R,et al.Prognostic significance of micrometastasis in non-small-cell lung cancer[J].Clin Lung Cancer,2004,5(4):214-215.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录